Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not?

Inflamm Bowel Dis. 2020 Jun 18;26(7):e71. doi: 10.1093/ibd/izaa110.

Authors

Roberto Grassia¹, Sara Soro¹, Clara Benedetta Conti¹

Affiliation

¹ Gastroenterology and Digestive Endoscopy Unit, ASST Cremona, Cremona, Italy.

No abstract available

Keywords: COVID-19; SARS-CoV-2; biological treatment; inflammatory bowel diseases.

Publication types

Comment

MeSH terms

Adult
Betacoronavirus
COVID-19
China
Coronavirus Infections
Humans
Inflammatory Bowel Diseases*
Inpatients
Pandemics
Pneumonia, Viral
Retrospective Studies
Risk Factors
SARS-CoV-2
Severe acute respiratory syndrome-related coronavirus*